Sarah P. Blagden
University of Oxford(GB)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer(2015)1,397 cited
- → Performance status score: do patients and their oncologists agree?(2003)220 cited
- → Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial(2019)217 cited
- → La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs(2017)193 cited
- → Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies(2011)166 cited
- → The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer(2015)159 cited
- → Polar expeditions — provisioning the centrosome for mitosis(2003)148 cited
- → Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development(2014)148 cited
- → LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression(2014)146 cited
- → The biological and therapeutic relevance of mRNA translation in cancer(2011)143 cited